The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Allergy relief-D
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride · CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Film Coated, Extended Release · Oral · Ohm Laboratories Inc.
NDC 51660-0940-12 · 2 BLISTER PACK in 1 CARTON / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for cetirizine hydrochloride, pseudoephedrine hydrochloride (oral solid) in the next 90 days
sole-source market · price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA090922
- TE code
- —
- Approval date
- Sep 28, 2012
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride (Tablet, Film Coated, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kenvue Brands LLC | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurohealth LLC | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Consortium,llc | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ohm Laboratories Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rite Aid | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strategic Sourcing Services Llc | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Walgreen Company | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Allergy relief-D — NDC 51660-0940-12," retrieved September 3, 2026, https://drugdashboards.com/drug/51660094012.
Free to cite with attribution — see how the data is put together.